ARK Investment Management LLC
Position in PRME — Prime Medicine, Inc.
CIK 1697748
ST. PETERSBURG, FL
Position in PRME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,806,872
+$9,067,915 QoQ
Shares Held
8,348,746
+33.6% QoQ
Ownership
4.60%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#3
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARK Investment Management LLC holds $1,628,434,493 across 17 Biotechnology names. PRME ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
9,460,939 | $515,999,613 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
10,234,862 | $351,260,463 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
16,875,684 | $285,536,573 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
41,337,632 | $151,709,109 | |
| 5 | ABSI |
Absci Corp
|
12,925,271 | $149,803,890 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
1,793,196 | $43,502,934 | |
| 7 | PRME |
Prime Medicine, Inc.
This page
|
8,348,746 | $30,806,872 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
300,770 | $23,848,053 |
All Filings in PRME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,806,872 | 8,348,746 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,738,957 | 6,246,827 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $18,628,785 | 5,368,526 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $30,347,294 | 5,477,851 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,736,992 | 2,322,669 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,159,392 | 3,095,172 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $15,038,680 | 5,150,233 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $21,906,982 | 5,660,719 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $31,491,613 | 6,126,773 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $41,953,478 | 5,993,354 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $27,805,072 | 3,138,270 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $25,017,972 | 2,622,429 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $35,880,765 | 2,449,199 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $23,644,007 | 1,922,277 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $30,470,902 | 1,639,984 | Shares | Sole | 2023-01-24 | |
| No filing history on record for this holder in this stock. | ||||||